07:00 , Oct 24, 2016 |  BC Week In Review  |  Company News

Antegrin, Cascadia deal

Antegrin and Cascadia merged to form Indalo Therapeutics Inc. (St. Louis, Mo.). The newco is developing treatments for fibrotic diseases affecting the kidney, liver, and lung using Antegrin’s portfolio of small molecule integrin antagonists, including...